|
Volumn 9, Issue 11, 2009, Pages 1541-1543
|
Harmonizing adult and pediatric approaches to the treatment of soft-tissue sarcoma
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DOCETAXEL;
DOXORUBICIN;
GEMCITABINE;
IFOSFAMIDE;
IMATINIB;
TAXANE DERIVATIVE;
TRABECTEDIN;
ADULT;
ANGIOSARCOMA;
CANCER CHEMOTHERAPY;
CANCER INCIDENCE;
CANCER THERAPY;
CHILD;
CLINICAL FEATURE;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
DERMATOFIBROSARCOMA PROTUBERANS;
DISEASE COURSE;
EDITORIAL;
HEALTH CARE DELIVERY;
HUMAN;
LEIOMYOSARCOMA;
LIPOSARCOMA;
MYXOSARCOMA;
OUTCOME ASSESSMENT;
PRACTICE GUIDELINE;
RARE DISEASE;
RHABDOMYOSARCOMA;
SOFT TISSUE SARCOMA;
STANDARDIZATION;
SYNOVIAL SARCOMA;
SYSTEMIC THERAPY;
TREATMENT RESPONSE;
ADULT;
AGE FACTORS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CHILD;
COMBINED MODALITY THERAPY;
HUMANS;
INTERDISCIPLINARY COMMUNICATION;
SARCOMA;
|
EID: 71949083033
PISSN: 14737140
EISSN: 17448328
Source Type: Journal
DOI: 10.1586/ERA.09.130 Document Type: Editorial |
Times cited : (6)
|
References (7)
|